FLT3LG and neoplasm: The study found that 60% of animals treated with ISCOMATRIXTM-mPAP-Poly I:C-Flt3L in a therapeutic prime-boost regimen showed complete tumor remission, and these tumor-free animals were protected from recurrence upon reexposure.